Related Experiment Videos

Ultraviolet light burn: a cutaneous complication of visible light phototherapy of neonatal jaundice

E C Siegfried1, M S Stone, K C Madison

  • 1Department of Dermatology, University of Iowa, Iowa City 52242.

Pediatric Dermatology
|September 1, 1992
PubMed

Insights

Visible light phototherapy effectively treats neonatal jaundice but can cause skin burns from ultraviolet A (UVA) exposure without protective shields. Premature infants are particularly vulnerable, necessitating vigilant use of Plexiglass shields during treatment.

Area of Science:

  • Neonatal Medicine
  • Dermatology
  • Phototherapy

Background:

  • Visible light phototherapy is a standard treatment for neonatal indirect hyperbilirubinemia.
  • Cutaneous side effects are known, including rashes and bronze baby syndrome.
  • Ultraviolet (UV) radiation exposure is a potential hazard.

Observation:

  • Two premature infants developed erythema, one with a second-degree burn.
  • This occurred due to prolonged ultraviolet A (UVA) exposure from fluorescent daylight bulbs used without Plexiglass shields.
  • Premature infants are highly susceptible to UVA-induced erythema, especially within the first two weeks of life.

Findings:

  • Inadvertent use of fluorescent daylight bulbs without Plexiglass shields can lead to hazardous UVA exposure.
  • This exposure can cause severe skin reactions, including burns, in premature infants.
  • Plexiglass shields are crucial for preventing UVA-induced erythema during phototherapy.

Implications:

  • Nursery staff must be educated on the critical importance of using Plexiglass shields during phototherapy.
  • Standard protocols should emphasize the consistent use of protective shields to prevent phototherapy-induced burns.
  • Ensuring shield placement is vital for infant safety during jaundice treatment.

Related Concept Videos